Lulihalt 1% Lotion contains luliconazole 1% w/v, a topical antifungal agent belonging to the imidazole class, indicated for the treatment of superficial fungal infections of the skin. Luliconazole exhibits broad-spectrum antifungal activity by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This formulation is primarily used in the management of dermatophytosis, including tinea corporis, tinea cruris, and tinea pedis, as well as candidal infections of the skin. Lulihalt 1% Lotion is applied once daily to the affected area and surrounding skin, ensuring thorough coverage and absorption. Clinical studies have demonstrated its efficacy in resolving symptoms such as erythema, scaling, and pruritus, with a favorable safety profile and minimal adverse effects, typically limited to mild local irritation or burning sensation. The lotion base facilitates ease of application and rapid skin penetration. It is contraindicated in patients with known hypersensitivity to luliconazole or any excipients. Use during pregnancy and lactation should be under medical supervision. Lulihalt 1% Lotion offers an effective and convenient option for the topical management of superficial fungal infections, promoting rapid clinical and mycological cure.